Atyr Pharma earnings were -$64.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ATYR earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$15.0M, down 13.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ATYR reported annual earnings of -$64.0M, with 27.1% growth. The next ATYR earnings date is Apr 30, 2025.
On ATYR's earnings call on Invalid Date, Atyr Pharma (NASDAQ: ATYR) reported Q4 2024 earnings per share (EPS) of -$0.17, up 32% year over year. Total ATYR earnings for the quarter were -$14.97 million. In the same quarter last year, Atyr Pharma's earnings per share (EPS) was -$0.25.
The next ATYR earnings date is Invalid Date. Add ATYR to your watchlist to be reminded of Atyr Pharma's next earnings date.
What was ATYR's earnings growth in the past year?
As of Atyr Pharma's earnings date in Invalid Date, Atyr Pharma's earnings has grown year over year. ATYR earnings in the past year totalled -$64.02 million.
Is Atyr Pharma profitable or losing money?
As of the last Atyr Pharma earnings report, Atyr Pharma is currently losing money. Atyr Pharma's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$64.02 million, a 27.06% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.